Sangita Palai
Research Subjects
Sangita Palai has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Kamalika Mazumder
B.C.D.A. College of Pharmacy & Technology
2 shared publications - Poulomi Biswas
Eminent College of Pharmaceutical Technology, Kolkata, India
2 shared publications - Chowdhury Mobaswar Hossain
Department of Pharmaceutical Technology, Maulana Abul Kalam Azad University of Technology Haringhata Campus, Nadia, West Bengal, India
1 shared publication - Debolina Banerjee
Department of Pharmacology and Biotechnology, Eminent College of Pharmaceutical Technology, Barbaria, Barasat, Kolkata, 700126, West Bengal, India
1 shared publication - Gouranga Nandi
Department of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur, Dist., Darjeeling, West Bengal 734013, India
1 shared publication Kaushik Biswas
Department of Pharmacology and Biotechnology, Eminent College of Pharmaceutical Technology, Barbaria, Barasat, Kolkata, 700126, West Bengal, India
1 shared publication
Latest Publications
- 4 November 2026
- Published by SAGE Publications in Toxicology and Industrial Health
The protective effect of flavonoids against carbon tetrachloride (CCl 4 )-induced hepatotoxicity
The liver is a remarkably stable auxiliary gland of the digestive system and a vital organ involved in numerous metabolic processes. Carbon tetrachloride (CCl 4 ) is a potent hepatotoxicant. It is well known that the conversion of CCl 4 to the highly reactive trichloromethyl (CCI 3 •) radical, which initiates the lipid peroxidation process, causes liver damage. This review critically summarizes in vitro and in vivo evidence on the hepatoprotective effects of plant-derived flavonoids against CCl 4 -induced liver damage and identifies promising therapeutic candidates and future research priorities. Numerous studies on flavonoids have demonstrated their ability to mitigate CCl 4 -induced hepatotoxicity via multiple pathways. Plant-derived flavonoids represent a promising hepatoprotective agent. Flavonoids are polyphenolic compounds with hepatoprotective, anti-inflammatory, and antioxidant properties, making them crucial for the development and treatment of pathological diseases. This study found that flavonoids are a potentially useful agent for hepatoprotection and that daily consumption of natural flavonoids plays a significant role in preventing diseases, particularly in liver damage. More accurate, dose-dependent clinical trials are still needed to treat hepatotoxicity safely with flavonoids.
- 4 November 2026
- Published by SAGE Publications in Toxicology and Industrial Health
The protective effect of flavonoids against carbon tetrachloride (CCl 4 )-induced hepatotoxicity
The liver is a remarkably stable auxiliary gland of the digestive system and a vital organ involved in numerous metabolic processes. Carbon tetrachloride (CCl 4 ) is a potent hepatotoxicant. It is well known that the conversion of CCl 4 to the highly reactive trichloromethyl (CCI 3 •) radical, which initiates the lipid peroxidation process, causes liver damage. This review critically summarizes in vitro and in vivo evidence on the hepatoprotective effects of plant-derived flavonoids against CCl 4 -induced liver damage and identifies promising therapeutic candidates and future research priorities. Numerous studies on flavonoids have demonstrated their ability to mitigate CCl 4 -induced hepatotoxicity via multiple pathways. Plant-derived flavonoids represent a promising hepatoprotective agent. Flavonoids are polyphenolic compounds with hepatoprotective, anti-inflammatory, and antioxidant properties, making them crucial for the development and treatment of pathological diseases. This study found that flavonoids are a potentially useful agent for hepatoprotection and that daily consumption of natural flavonoids plays a significant role in preventing diseases, particularly in liver damage. More accurate, dose-dependent clinical trials are still needed to treat hepatotoxicity safely with flavonoids.
- 10 October 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (12) , e01947
Inhibition of Biofilm Formation and Cell Wall Targeting Activity of Endophytic Nocardiopsis Strain KDCGRAW Isolated From the Indian Sundarbans
The discovery of new antimicrobials is one of the most crucial approaches to tackling the antimicrobial resistance crisis. Strain KDCGRAW was isolated from the root of Rhizophora apiculata (Garjan tree) from the Bonnie camp subdivision of Sundarbans, West Bengal, India. 16S rRNA gene sequencing analysis revealed that the strain belongs to the genus Nocardiopsis . The strain was subjected to fermentation, and the crude extract was analyzed using GC–MS. The extract inhibited Escherichia coli MTCC 1195 biofilm formation and showed a percentage biofilm remaining of 77.69% for 1/2 MIC, 69.18% for MIC, and 51.56% for 2 MIC, respectively. However, MIC and 2 MIC doses of the extract showed a significant biofilm formation inhibition and the percentage biofilm remaining determined was 51.89% and 43.97%, respectively, as compared to the 1/2 MIC 74.93% against Staphylococcus aureus MTCC 2940. The in silico docking and molecular dynamics study revealed that compound 1 and compound 9 exhibited the best docking energies with the two selected biofilm‐associated proteins, achieving binding energies of −6.84 and −7.7 kcal/mol on 5XP0 and 7C7R, respectively. In vivo toxicity analysis using brine shrimp revealed that the extract was nontoxic at all the concentration ranges, namely, 1/2 MIC, MIC, and 2 MIC.
- 10 October 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (12) , e01947
Inhibition of Biofilm Formation and Cell Wall Targeting Activity of Endophytic Nocardiopsis Strain KDCGRAW Isolated From the Indian Sundarbans
The discovery of new antimicrobials is one of the most crucial approaches to tackling the antimicrobial resistance crisis. Strain KDCGRAW was isolated from the root of Rhizophora apiculata (Garjan tree) from the Bonnie camp subdivision of Sundarbans, West Bengal, India. 16S rRNA gene sequencing analysis revealed that the strain belongs to the genus Nocardiopsis . The strain was subjected to fermentation, and the crude extract was analyzed using GC–MS. The extract inhibited Escherichia coli MTCC 1195 biofilm formation and showed a percentage biofilm remaining of 77.69% for 1/2 MIC, 69.18% for MIC, and 51.56% for 2 MIC, respectively. However, MIC and 2 MIC doses of the extract showed a significant biofilm formation inhibition and the percentage biofilm remaining determined was 51.89% and 43.97%, respectively, as compared to the 1/2 MIC 74.93% against Staphylococcus aureus MTCC 2940. The in silico docking and molecular dynamics study revealed that compound 1 and compound 9 exhibited the best docking energies with the two selected biofilm‐associated proteins, achieving binding energies of −6.84 and −7.7 kcal/mol on 5XP0 and 7C7R, respectively. In vivo toxicity analysis using brine shrimp revealed that the extract was nontoxic at all the concentration ranges, namely, 1/2 MIC, MIC, and 2 MIC.
- 1 September 2025
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 25 (6) , 40-55
Exploration of Phytochemicals as Anti-biofilm Agents against Pathogenic Bacteria: Their Potential and Challenges
Multicellular surface-attached populations of bacteria embedded in the extracellular matrix are known as biofilms. Bacteria generally preferred to grow as biofilms. Quorum sensing (QS), detection of density of cell population through gene regulation, has been found to play an important role in the production of biofilms. Biofilm formation can increase the severity of infections that can lead to morbidity or mortality. Bacteria living within biofilms have a higher pattern of adaptive resistance to antibiotics. Antibiotic resistance is a barrier in the treatment of biofilmsinduced acute to chronic infections such as post-surgery infections, surgery-associated wound infections, endocarditis, joint infections, burn-related wound infections occurred, ventilator-associated pneumonia, etc. So it is urgent to discover or find out potent new drugs in fight against infectious diseases such as biofilms-associated infections. Medicinal plants or herbs are a rich source for fighting with biofilms-mediated infections. Phytochemicals have exhibited significant effects in the prevention of biofilms formation against different bacteria that are causing infections. Purified compounds such as berberine, tetrandrine, embelin, xanthorrhizol, bakuchiol, etc., exhibited promising biofilm inhibition actions against different pathogenic bacteria. Plant extracts that contain several phytochemicals are evaluated for its biofilm’s inhibition property, and have shown significant potential in biofilm formation. Antibiofilm agents act by distinct mechanisms such as inhibiting the adherence of biofilms in a surface, preventing the biofilm formations, disrupting the matured biofilms, etc. This study is intended to reiterate about possibilities of plant extracts and purified compounds in the treatment of the prevention of bacterial biofilms-related infections.
- 1 September 2025
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 25 (6) , 40-55
Exploration of Phytochemicals as Anti-biofilm Agents against Pathogenic Bacteria: Their Potential and Challenges
Multicellular surface-attached populations of bacteria embedded in the extracellular matrix are known as biofilms. Bacteria generally preferred to grow as biofilms. Quorum sensing (QS), detection of density of cell population through gene regulation, has been found to play an important role in the production of biofilms. Biofilm formation can increase the severity of infections that can lead to morbidity or mortality. Bacteria living within biofilms have a higher pattern of adaptive resistance to antibiotics. Antibiotic resistance is a barrier in the treatment of biofilmsinduced acute to chronic infections such as post-surgery infections, surgery-associated wound infections, endocarditis, joint infections, burn-related wound infections occurred, ventilator-associated pneumonia, etc. So it is urgent to discover or find out potent new drugs in fight against infectious diseases such as biofilms-associated infections. Medicinal plants or herbs are a rich source for fighting with biofilms-mediated infections. Phytochemicals have exhibited significant effects in the prevention of biofilms formation against different bacteria that are causing infections. Purified compounds such as berberine, tetrandrine, embelin, xanthorrhizol, bakuchiol, etc., exhibited promising biofilm inhibition actions against different pathogenic bacteria. Plant extracts that contain several phytochemicals are evaluated for its biofilm’s inhibition property, and have shown significant potential in biofilm formation. Antibiofilm agents act by distinct mechanisms such as inhibiting the adherence of biofilms in a surface, preventing the biofilm formations, disrupting the matured biofilms, etc. This study is intended to reiterate about possibilities of plant extracts and purified compounds in the treatment of the prevention of bacterial biofilms-related infections.